|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shaib YH, Davila JA, McGlynn K and
El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in
the United States: A true increase? J Hepatol. 40:472–477. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Welzel TM, Graubard BI, El-Serag HB, Shaib
YH, Hsing AW, Davila JA and McGlynn KA: Risk factors for
intrahepatic and extrahepatic cholangiocarcinoma in the United
States: A population-based case-control study. Clin Gastroenterol
Hepatol. 5:1221–1228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xiong J, Wang Y, Huang H, Bian J, Wang A,
Long J, Zheng Y, Sang X, Xu Y, Lu X, et al: Systematic review and
meta-analysis: Cholecystectomy and the risk of cholangiocarcinoma.
Oncotarget. 8:59648–59657. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu S, Jiang B, Li H, He Z, Lv P, Peng C,
Wang Y, Cheng W, Xu Z, Chen W, et al: Wip1 is associated with
tumorigenity and metastasis through MMP-2 in human intrahepatic
cholangiocarcinoma. Oncotarget. 8:56672–56683. 2017.PubMed/NCBI
|
|
6
|
Dover LL, Jacob R, Wang TN, Richardson JH,
Redden DT, Li P and DuBay DA: Improved postoperative survival for
intraductal-growth subtype of intrahepatic cholangiocarcinoma. Am
Surg. 82:1133–1139. 2016.
|
|
7
|
Smith-Cohn MA, Gill D, Voorhies BN,
Agarwal N and Garrido-Laguna I: Case report: Pembrolizumab-induced
type 1 diabetes in a patient with metastatic cholangiocarcinoma.
Immunotherapy. 9:797–804. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang J, Liu Y, Wang B, Lan H, Liu Y, Chen
F, Zhang J and Luo J: Sumoylation in p27kip1 via RanBP2 promotes
cancer cell growth in cholangiocarcinoma cell line QBC939. BMC Mol
Biol. 18:232017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Loosen SH, Roderburg C, Kauertz KL,
Pombeiro I, Leyh C, Benz F, Vucur M, Longerich T, Koch A,
Braunschweig T, et al: Elevated levels of circulating osteopontin
are associated with a poor survival after resection of
cholangiocarcinoma. J Hepatol. 67:749–757. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Svoboda P: Long and small noncoding RNAs
during oocyte-to-embryo transition in mammals. Biochem Soc Trans.
45:1117–1124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu
P, Du Y, Wu J, Qin X, Chen R, et al: Long noncoding RNA lncKdm2b is
required for ILC3 maintenance by initiation of Zfp292 expression.
Nat Immunol. 18:499–508. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L, et al: LncBRM initiates YAP1 signalling
activation to drive self-renewal of liver cancer stem cells. Nat
Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu YC, Liang CJ, Zhang DX, Li GQ, Gao X,
Fu JZ, Xia F, Ji JJ, Zhang LJ, Li GM, et al: LncSHRG promotes
hepatocellular carcinoma progression by activatingHES6. Oncotarget.
8:70630–70641. 2017.PubMed/NCBI
|
|
14
|
Monteleone NJ and Lutz CS: miR-708-5p: A
microRNA with emerging roles in cancer. Oncotarget. 8:71292–71316.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Faghihi F and Moustafa AA: Impaired
neurogenesis of the dentate gyrus is associated with pattern
separation deficits: A computational study. J Integr Neurosci.
15:277–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu Y, Leng K, Li Z, Zhang F, Zhong X, Kang
P, Jiang X and Cui Y: The prognostic potential and carcinogenesis
of long non-coding RNA TUG1 in human cholangiocarcinoma.
Oncotarget. 8:65823–65835. 2017.PubMed/NCBI
|
|
17
|
Shi X, Zhang H, Wang M, Xu X, Zhao Y, He
R, Zhang M, Zhou M, Li X, Peng F, et al: LncRNA AFAP1-AS1 promotes
growth and metastasis of cholangiocarcinoma cells. Oncotarget.
8:58394–58404. 2017.PubMed/NCBI
|
|
18
|
Li J, Zhang Q, Fan X, Mo W, Dai W, Feng J,
Wu L, Liu T, Si L, Xu S, et al: The long noncoding RNA TUG1 acts as
a competing endogenous RNA to regulate the Hedgehog pathway by
targeting miR-132 in hepatocellular carcinoma. Oncotarget.
8:65932–65945. 2017.PubMed/NCBI
|
|
19
|
Wang Y, Zhang Y, Yang T, Zhao W, Wang N,
Li P, Zeng X and Zhang W: Long non-coding RNA MALAT1 for promoting
metastasis and proliferation by acting as a ceRNA of miR-144-3p in
osteosarcoma cells. Oncotarget. 8:59417–59434. 2017.PubMed/NCBI
|
|
20
|
Puik JR, Meijer LL, Le Large TYS, Prado
MM, Frampton AE, Kazemier G and Giovannetti E: miRNA profiling for
diagnosis, prognosis and stratification of cancer treatment in
cholangiocarcinoma. Pharmacogenomics. 18:1343–1358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Q, Tang H, Yin S and Dong C:
Downregulation of microRNA-138 enhances the proliferation,
migration and invasion of cholangiocarcinoma cells through the
upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep. 29:2046–2052.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu P, Wang Y, Huang G, Ye B, Liu B, Wu J,
Du Y, He L and Fan Z: lnc-β-Catm elicits EZH2-dependent β-catenin
stabilization and sustains liver CSC self-renewal. Nat Struct Mol
Biol. 23:631–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP
and Gao YF: LncSox4 promotes the self-renewal of liver
tumour-initiating cells through Stat3-mediated Sox4 expression. Nat
Commun. 7:125982016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang P and Lv L: miR-26a induced the
suppression of tumor growth of cholangiocarcinoma via KRT19
approach. Oncotarget. 7:81367–81376. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao L and Zhang Y and Zhang Y: Long
noncoding RNA CASC2 regulates hepatocellular carcinoma cell
oncogenesis through miR-362-5p/Nf-κB axis. J Cell Physiol. Jan
10–2018.Epub ahead of print. View Article : Google Scholar
|
|
26
|
Zhu S, Zhang X, Weichert-Leahey N, Dong Z,
Zhang C, Lopez G, Tao T, He S, Wood AC, Oldridge D, et al: LMO1
synergizes with MYCN to promote neuroblastoma initiation and
metastasis. Cancer Cell. 32:310–323.e5. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao Y, Jin Y, Yu J, Wang J, Qiu Y, Duan X,
Ye Y, Cheng Y, Dong L, Feng X, et al: Clinical evaluation of
integrated panel testing by next-generation sequencing for somatic
mutations in neuroblastomas with MYCN unamplification. Oncotarget.
8:49689–49701. 2017.PubMed/NCBI
|
|
28
|
Ambrosio S, Amente S, Saccà CD, Capasso M,
Calogero RA, Lania L and Majello B: LSD1 mediates MYCN control of
epithelial-mesenchymal transition through silencing of metastatic
suppressor NDRG1 gene. Oncotarget. 8:3854–3869. 2017. View Article : Google Scholar :
|
|
29
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu JM: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu G, Dong B, Zhang J, Zhai W, Xie T,
Huang B, Huang C, Yao X, Zheng J, Che J, et al: The long noncoding
RNA HOTAIR activates the Hippo pathway by directly binding to SAV1
in renal cell carcinoma. Oncotarget. 8:58654–58667. 2017.PubMed/NCBI
|
|
31
|
Wu F, Zhang C, Cai J, Yang F, Liang T, Yan
X, Wang H, Wang W, Chen J and Jiang T: Upregulation of long
noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor
prognosis in glioma. Oncotarget. 8:53110–53123. 2017.PubMed/NCBI
|
|
32
|
Wu J, Cheng G, Zhang C, Zheng Y, Xu H,
Yang H and Hua L: Long noncoding RNA LINC01296 is associated with
poor prognosis in prostate cancer and promotes cancer-cell
proliferation and metastasis. Onco Targets Ther. 10:1843–1852.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yuan Z, Yu X, Ni B, Chen D, Yang Z, Huang
J, Wang J, Chen D and Wang L: Overexpression of long non-coding
RNA-CTD903 inhibits colorectal cancer invasion and migration by
repressing Wnt/β-catenin signaling and predicts favorable
prognosis. Int J Oncol. 48:2675–2685. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Seitz AK, Christensen LL, Christensen E,
Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM,
Palmfeldt J, Thomson M, et al: Profiling of long non-coding RNAs
identifies LINC00958 and LINC01296 as candidate oncogenes in
bladder cancer. Sci Rep. 7:3952017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tsubota S, Kishida S, Shimamura T, Ohira
M, Yamashita S, Cao D, Kiyonari S, Ushijima T and Kadomatsu K:
PRC2-mediated transcriptomic alterations at the embryonic stage
govern tumorigenesis and clinical outcome in MYCN-Driven
neuroblastoma. Cancer Res. 77:5259–5271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun G, Lu J, Zhang C, You R, Shi L, Jiang
N, Nie D, Zhu J, Li M and Guo J: MiR-29b inhibits the growth of
glioma via MYCN dependent way. Oncotarget. 8:45224–45233.
2017.PubMed/NCBI
|
